An engineered periosteum for efficient delivery of rhBMP-2 and mesenchymal progenitor cells during bone regeneration
Romero-Torrecilla, J.A.; Lamo-Espinosa, J.M.; Ripalda-Cemboráin, P.; López-Martínez, T.; Abizanda, G.; Riera-Álvarez, L.; de Galarreta-Moriones, S.R.; López-Barberena, A.; Rodríguez-Flórez, N.; Elizalde, R.; Jayawarna, V.; Valdés-Fernández, J.; de Anleo, M.E.-G.; Childs, P.; de Juan-Pardo, E.; Salmeron-Sanchez, M.; Prósper, F.; Muiños López, Emma; Granero-Moltó, F.
Identificadores
Identificadores
Visualización o descarga de ficheros
Visualización o descarga de ficheros
Fecha de publicación
2023Título de revista
npj Regenerative Medicine
Tipo de contenido
Artigo
Resumen
During bone regeneration, the periosteum acts as a carrier for key regenerative cues, delivering osteochondroprogenitor cells and crucial growth factors to the injured bone. We developed a biocompatible, 3D polycaprolactone (PCL) melt electro-written membrane to act as a mimetic periosteum. Poly (ethyl acrylate) coating of the PCL membrane allowed functionalization, mediated by fibronectin and low dose recombinant human BMP-2 (rhBMP-2) (10-25 ?g/ml), resulting in efficient, sustained osteoinduction in vitro. In vivo, rhBMP-2 functionalized mimetic periosteum demonstrated regenerative potential in the treatment of rat critical-size femoral defects with highly efficient healing and functional recovery (80%-93%). Mimetic periosteum has also proven to be efficient for cell delivery, as observed through the migration of transplanted periosteum-derived mesenchymal cells to the bone defect and their survival. Ultimately, mimetic periosteum demonstrated its ability to deliver key stem cells and morphogens to an injured site, exposing a therapeutic and translational potential in vivo when combined with unprecedentedly low rhBMP-2 doses.
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International (CC BY 4.0)











